These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 28197337

  • 1. Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis.
    Pender MP, Csurhes PA, Burrows JM, Burrows SR.
    Clin Transl Immunology; 2017 Jan; 6(1):e126. PubMed ID: 28197337
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
    Nowakowska J, Stuehler C, Egli A, Battegay M, Rauser G, Bantug GR, Brander C, Hess C, Khanna N.
    Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B, Rosicarelli B, Veroni C, Mazzola GA, Aloisi F.
    J Virol; 2019 Dec 15; 93(24):. PubMed ID: 31578295
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of suitable target antigens and immunoassays for high-accuracy immune monitoring of cytomegalovirus and Epstein-Barr virus-specific T cells as targets of interest in immunotherapeutic approaches.
    Tischer S, Dieks D, Sukdolak C, Bunse C, Figueiredo C, Immenschuh S, Borchers S, Stripecke R, Maecker-Kolhoff B, Blasczyk R, Eiz-Vesper B.
    J Immunol Methods; 2014 Jun 15; 408():101-13. PubMed ID: 24877879
    [Abstract] [Full Text] [Related]

  • 7. Decreased CD8+ T cell response to Epstein-Barr virus infected B cells in multiple sclerosis is not due to decreased HLA class I expression on B cells or monocytes.
    Pender MP, Csurhes PA, Pfluger CM, Burrows SR.
    BMC Neurol; 2011 Aug 03; 11():95. PubMed ID: 21810280
    [Abstract] [Full Text] [Related]

  • 8. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis.
    Angelini DF, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F, Centonze D, Mechelli R, Salvetti M, Borsellino G, Aloisi F, Battistini L.
    PLoS Pathog; 2013 Aug 03; 9(4):e1003220. PubMed ID: 23592979
    [Abstract] [Full Text] [Related]

  • 9. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA.
    Brain; 2008 Jul 03; 131(Pt 7):1712-21. PubMed ID: 18550621
    [Abstract] [Full Text] [Related]

  • 10. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD, Edwards N, Muraro PA, Hayashi S, Cohen JI, Münz C, Martin R.
    Brain; 2006 Jun 03; 129(Pt 6):1493-506. PubMed ID: 16569670
    [Abstract] [Full Text] [Related]

  • 11. Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.
    Klatt T, Ouyang Q, Flad T, Koetter I, Bühring HJ, Kalbacher H, Pawelec G, Müller CA.
    J Rheumatol; 2005 Feb 03; 32(2):239-51. PubMed ID: 15693083
    [Abstract] [Full Text] [Related]

  • 12. Novel method for detection of virus-specific CD41+ T cells indicates a decreased EBV-specific CD4+ T cell response in untreated HIV-infected subjects.
    Piriou ER, van Dort K, Nanlohy NM, van Oers MH, Miedema F, van Baarle D.
    Eur J Immunol; 2005 Mar 03; 35(3):796-805. PubMed ID: 15724243
    [Abstract] [Full Text] [Related]

  • 13. Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins.
    van Nierop GP, Mautner J, Mitterreiter JG, Hintzen RQ, Verjans GM.
    Mult Scler; 2016 Mar 03; 22(3):279-91. PubMed ID: 26041797
    [Abstract] [Full Text] [Related]

  • 14. HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis.
    Jilek S, Schluep M, Harari A, Canales M, Lysandropoulos A, Zekeridou A, Pantaleo G, Du Pasquier RA.
    J Immunol; 2012 May 01; 188(9):4671-80. PubMed ID: 22461701
    [Abstract] [Full Text] [Related]

  • 15. Combination of Epstein-Barr virus nuclear antigen 1, 3 and lytic antigen BZLF1 peptide pools allows fast and efficient stimulation of Epstein-Barr virus-specific T cells for adoptive immunotherapy.
    Wang Y, Aïssi-Rothe L, Virion JM, De Carvalho Bittencourt M, Ulas N, Audonnet S, Salmon A, Clement L, Venard V, Jeulin H, Stoltz JF, Decot V, Bensoussan D.
    Cytotherapy; 2014 Jan 01; 16(1):122-34. PubMed ID: 24094498
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy.
    Kalra M, Gerdemann U, Luu JD, Ngo MC, Leen AM, Louis CU, Rooney CM, Gottschalk S.
    Cytotherapy; 2019 Feb 01; 21(2):212-223. PubMed ID: 30396848
    [Abstract] [Full Text] [Related]

  • 17. Identification of Epstein-Barr virus-specific CD8+ T lymphocytes in the circulation of pediatric transplant recipients.
    Falco DA, Nepomuceno RR, Krams SM, Lee PP, Davis MM, Salvatierra O, Alexander SR, Esquivel CO, Cox KL, Frankel LR, Martinez OM.
    Transplantation; 2002 Aug 27; 74(4):501-10. PubMed ID: 12352909
    [Abstract] [Full Text] [Related]

  • 18. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.
    Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, Pamer EG, Howe JG, Craft J.
    J Immunol; 2004 Jan 15; 172(2):1287-94. PubMed ID: 14707107
    [Abstract] [Full Text] [Related]

  • 19. Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation.
    Vogl BA, Fagin U, Nerbas L, Schlenke P, Lamprecht P, Jabs WJ.
    J Med Virol; 2012 Jan 15; 84(1):119-31. PubMed ID: 22095540
    [Abstract] [Full Text] [Related]

  • 20. Epstein-Barr virus peptide presented by HLA-E is predominantly recognized by CD8(bright) cells in multiple sclerosis patients.
    Jørgensen PB, Livbjerg AH, Hansen HJ, Petersen T, Höllsberg P.
    PLoS One; 2012 Jan 15; 7(9):e46120. PubMed ID: 23049954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.